New HCV Test Enables Diagnosis and Treatment in a Single Visit
XTalks
JULY 10, 2024
The US Food and Drug Administration (FDA) has granted marketing authorization to Cepheid for its groundbreaking Xpert HCV test and GeneXpert Xpress System, marking a significant advancement in the diagnosis and treatment of hepatitis C virus (HCV). North America dominated the market in 2018 with a 47.46 percent share.
97 
Let's personalize your content